Prothrombinase induced clotting time (PiCT®) for measuring the activity of direct factor Xa inhibitors in clinical setting

被引：0
|
作者：
Olivera, P. E. [1 ]
Cortina, V [1 ]
Pons, V [1 ]
Merchan, B. [2 ]
Lopez-Andreoni, L. [1 ]
Artaza, G. [1 ]
Menino, E. [3 ]
Marin, A. [2 ]
Bosch, F. [2 ]
Santamaria, A. [1 ]
机构：
[1] Univ Hosp Vall dHebron, Hemostasis & Thrombosis Unit, Barcelona, Spain
[2] Univ Hosp Vall dHebron, Dept Hematol, Barcelona, Spain
[3] Primary Healthcare Ctr Rio de Janeiro Prosperitat, Barcelona, Spain
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO375-TUE
引用
收藏
页码：643 / 643
页数：1
相关论文
共 50 条
  • [1] Preincubation in the Prothrombinase-induced Clotting Time test (PiCT) is necessary for in vitro evaluation of fondaparinux and to be avoided for the reversible, direct factor Xa inhibitor, rivaroxaban
    Kluft, C.
    Meijer, P.
    Kret, R.
    Burggraaf, J.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 (04) : 379 - 384
  • [2] Monitoring of parenteral anticoagulant drugs with the prothrombinase induced clotting time (PICT)
    Hoppensteadt, D.
    Walenga, J. M.
    Cunanan, J.
    Iqbal, O.
    Fareed, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 569 - 569
  • [3] Prothrombinase induced clotting time (PICT) for the monitoring of new oral anticoagulants
    Hoppensteadt, D.
    Walenga, J. M.
    Cunanan, J.
    Iqbal, O.
    Fareed, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 824 - 825
  • [4] Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): Relation to FXa-activity and influence of assay modifications
    Harder, Sebastian
    Parisius, Jeannine
    Picard-Willems, Bettina
    THROMBOSIS RESEARCH, 2008, 123 (02) : 396 - 403
  • [5] DIFFERENT SPECIFICITY OF THE 2-STEP AND 1-STEP PROTHROMBINASE INDUCED CLOTTING TIME FOR FACTOR XA-INHIBITORS
    Burggraaf, K.
    Moerland, M.
    Kluft, C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 50 - 50
  • [6] Monitoring recombinant hirudin therapy using the Ecarin Clotting Time;: Heptest® and the prothrombinase induced clotting test (PiCT®).
    Calatzis, A
    Haas, S
    Wilmer, M
    Bühler, B
    Spannagl, M
    BLOOD, 2000, 96 (11) : 91B - 91B
  • [7] The prothrombinase induced clotting time test (PICT®), a robust alternative to aptt in the management of ufh therapy
    Korte, W.
    Marlar, R.
    Krause, M.
    Rathbun, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 18 - 19
  • [8] Monitoring high-dose heparinization during cardiopulmonary by-pass -: A comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays
    Raivio, Peter
    Kuitunen, Anne
    Petaja, Jari
    Ilveskero, Sorella
    Lassila, Riitta
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) : 427 - 434
  • [9] Development of prothrombinase induced clotting time (Pefakit®, PiCT) assay and its validation in the monitoring of anti-Xa and anti-FIIa drugs.
    Hoppensteadt, DA
    Cunanan, J
    Walenga, JM
    Fareed, J
    BLOOD, 2004, 104 (11) : 514A - 514A
  • [10] Monitoring of unfractionated heparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent (PiCT®)
    Schaden, E.
    Jilch, S.
    Hacker, S.
    Schober, A.
    Kozek-Langenecker, S.
    CLINICA CHIMICA ACTA, 2012, 414 : 202 - 205
12345